Senior insider sale
Chief Operating Officer at PALVELLA THERAPEUTICS, INC. — senior position signals high conviction
$2.49M
17.22K shares
What this filing means
GOIN KATHLEEN plans to sell 17.22K shares of PALVELLA THERAPEUTICS, INC. valued at approximately $2.49M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/21/2026ACC: 0001967940-26-000055
Officer· Chief Operating Officer
Since Feb 2026
17.22K
Shares to sell
$2.49M
Approx. market value
4.31K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
10/21/2026
4.31KTotal acquired4.31K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/21/2026 | Stock Option Exercise Cash | 4.31K | — |
| Total | 4.31K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
4.30K
Market value
$654.9K
9/16/2026
—Completed
Units to sell
4.30K
Market value
$654.8K
8/19/2026
—Completed
Units to sell
4.30K
Market value
$642.2K
7/15/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
4.31K
Market value
$534.5K
10/21/2026
Total
Units
17.22K
Value
$2.49M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/16/2026 | 4.30K | $654.9K | — | Completed |
8/19/2026 | 4.30K | $654.8K | — | Completed |
7/15/2026 | 4.30K | $642.2K | — | Completed |
| Planned — Approximate Date | ||||
10/21/2026 | 4.31K | $534.5K | Nasdaq | Planned |
| Total | 17.22K | $2.49M | ||